Filing Details

Accession Number:
0001486189-23-000026
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-08 12:12:25
Reporting Period:
2023-08-25
Accepted Time:
2023-09-08 12:12:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1870144 Cardio Diagnostics Holdings Inc. CDIO In Vitro & In Vivo Diagnostic Substances (2835) 870925574
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1950663 Timur Dogan 311 W Superior St, Ste 444
Chicago IL 60654
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-08-25 1,770 $0.56 111,864 No 4 P Direct
Common Stock Acquisiton 2023-08-31 16,481 $0.55 128,345 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.55 to $0.56 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.54 to $0.55 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.